Helsinki-based MVision AI raises €5.4 million to speed up cancer treatment
Summary
Founded in 2017 in Helsinki, MVision AI has developed an AI-based solution to change that outlook, offering same-day treatment planning software. Developed by Mahmudul Hasan, Jarkko Niemelä and Saad Ullah Akram, MVision AI provides a cloud-based SaaS solution for radiotherapy treatment planning. The tool automates cancer treatment with AI-powered automatic segmentation that helps to standardize contouring and streamline the planning workflow. So far, the healthtech innovation has been used to treat more than 100k patients in 14 countries around the world, including Finland, Sweden, Spain, France, the UK and the USA. Chihray Liu, PhD, DABR, FAAPM Professor and Chief of Physics-Gainesville Department of Radiation Oncology, University of Florida: “We were immediately impressed by the quality and consistency of MVision’s AI auto-segmentation.
Funding
Review available funding amount, funding date, investors, and linked company information related to Helsinki-based MVision AI raises €5.4 million to speed up cancer treatment in the interactive ISVWorld profile.